StonvexLoading…
StonvexStonvexStonvexCore line items from ALHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2023 2023-12-31 | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $1.80B | $1.34B | $891.69M | $434.81M |
Operating Income | $-127.82M | $-85.90M | $-56.15M | $-32.49M |
Net Income | $-148.02M | $-100.81M | $-65.76M | $-37.28M |
EPS (Diluted) | $-0.79 | $-0.54 | $-0.36 | $-0.20 |
Total Assets | $591.88M | $770.79M | $783.55M | $761.75M |
Total Liabilities | $433.81M | $581.19M | $572.43M | $537.81M |
Cash & Equivalents | $202.90M | $391.64M | $395.26M | $384.26M |
Free Cash Flow OCF − CapEx | $-95.18M | $102.88M | $106.44M | $77.83M |
Shares Outstanding | 188.95M | 188.91M | 188.51M | 188.48M |